David Coman - Aug 12, 2023 Form 4 Insider Report for Science 37 Holdings, Inc. (SNCE)

Role: Chief Executive Officer
Signature: /s/ Christine Pellizzari, Attorney-in-fact for David Coman
Stock symbol: SNCE
Transactions as of: Aug 12, 2023
Transactions value $: -$63,613
Form type: 4
Date filed: 8/15/2023, 05:30 PM
Previous filing: May 2, 2023
Next filing: Mar 12, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SNCE	Common Stock	Options Exercise	$0	+495K	+36.9%	$0.00	1.84M	Aug 12, 2023	Direct	F1
transaction	SNCE	Common Stock	Tax liability	-$63.6K	-145K	-7.87%	$0.44	1.69M	Aug 12, 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SNCE	Restricted Stock Units	Options Exercise	$0	-495K	-33.33%	$0.00	990K	Aug 12, 2023	Common Stock	495K		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Acquisition of common stock resulting from vesting of the restricted stock units granted to Mr. Coman on August 12, 2022.
F2	Disposition of common stock resulting from the withholding of securities for the payment of tax liability relating to the vesting of restricted stock units granted to Mr. Coman on August 12, 2022.
F3	Each restricted stock unit represents a contingent right to receive one share of Science 37 Holdings, Inc.'s common stock.
F4	On August 12, 2022, Mr. Coman received restricted stock units representing 1,485,365 shares subject to a three-year vesting schedule, vesting 33 1/3% on the first, second and third anniversaries of the grant date. As restricted stock units vest, the vested units are automatically converted to vested common stock on a one-for-one basis on the vesting date.